Hims & Hers Health, Inc. (HIMS) Stock Score, Valuation & Financial Research
Hims & Hers Health, Inc. is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 26/100.
Quick answer for HIMS
Hims & Hers Health, Inc. currently has a Wall Street Score of 26/100. The stored market price is $29.07. Its financial score is 22/100. Its valuation score is 4/100. The latest WSS change is +3.0 points. These figures are a research snapshot, not a buy or sell recommendation.
What Hims & Hers Health, Inc. does
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrat
HIMS financial snapshot
- Wall Street Score:
- 26/100
- Current price:
- $29.07
- Market capitalization:
- $6.48B
- Revenue:
- $2.58B
- Net income:
- $-142.0M
- Free cash flow:
- $74.0M
- Cash:
- $609.8M
- Total debt:
- $1.55B
- EPS:
- 0.57
- P/E ratio:
- 51.0x
- Financial score:
- 22/100
- Valuation score:
- 4/100
- Revenue score:
- 34/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $74.0M, showing positive cash generation.
- The balance sheet shows $609.8M of cash versus $1.55B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +3.0 points: HIMS increased 3 points because Revenue improved by 9.6 points, Asset improved by 5.4 points, Management improved by 14 points.
What the numbers mean
Its current valuation score is 4/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 22/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research HIMS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.